Skip to main content
VCbacked
Log inGet Started

DalCor Pharmaceuticals

Montreal, Canada

DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits

$80.0M raised
Sep 2023
Series D
GeneticsHealth CareMedicalPharmaceutical

Top Investors

Caisse de Depot et Placement du QuebecFonds de solidarite FTQAndesInvestissement QuebecCTI Life Sciences Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about DalCor Pharmaceuticals

How much funding has DalCor Pharmaceuticals raised?
DalCor Pharmaceuticals has raised $80.0M in total funding. The most recent round was Series D. The last funding was announced in September 2023.
Who are DalCor Pharmaceuticals's investors?
DalCor Pharmaceuticals's investors include Caisse de Depot et Placement du Quebec, Fonds de solidarite FTQ, Andes, Investissement Quebec, CTI Life Sciences Fund.
Where is DalCor Pharmaceuticals headquartered?
DalCor Pharmaceuticals is headquartered in Montreal, Canada.
What does DalCor Pharmaceuticals do?
DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits
What stage is DalCor Pharmaceuticals at?
DalCor Pharmaceuticals is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"DalCor Pharmaceuticals — Funding & Investors." VCBacked, September 13, 2023, https://www.vcbacked.co/company/dalcor-pharmaceuticals. Accessed June 16, 2026.
APA
VCBacked. (2023). DalCor Pharmaceuticals — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/dalcor-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=DalCor Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/dalcor-pharmaceuticals |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Genetics

View all
Prenetics
Hong Kong
Latus Bio
Philadelphia
Kytopen
Cambridge
Maze Therapeutics
South San Francisco
ReviR Therapeutics
Brisbane
SWAN Genomics
Sydney$317K